Norman David Eansor - Mar 16, 2021 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
Mar 16, 2021
Transactions value $
$249,988
Form type
4
Date filed
6/8/2023, 09:35 PM
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRKR Common Stock Purchase $250K +14.3K +588.34% $17.50 16.7K Mar 16, 2021 Direct F1
transaction MRKR Common Stock Gift $0 -14.3K -85.47% $0.00 2.43K Mar 25, 2021 Direct F1, F2
transaction MRKR Common Stock Gift $0 +7.14K $0.00 7.14K Mar 25, 2021 By the John R. Eansor 2020 Exempt Trust F1, F2
transaction MRKR Common Stock Gift $0 +7.14K $0.00 7.14K Mar 25, 2021 By the Scott Eansor 2020 Exempt Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (right to buy) Award $0 +8K $0.00 8K Jun 6, 2023 Common Stock 8K $1.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a 10-1 reverse stock split which became effective on January 16, 2023.
F2 The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust.
F3 This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.